Metastatic or Locally Advanced Cancer
1 clinical trials · Condition
◉ Watch Metastatic or Locally Advanced Cancer
| Record | Firm | Date |
|---|---|---|
| A Study to Evaluate the Effect of MK-8669 (Ridaforolimus) on QTc Interval in Participants With Advanced Cancer (MK-8669-037) (NCT00874731) | Merck Sharp & Dohme LLC | 2009-04-28 |
Track Metastatic or Locally Advanced Cancer automatically
Every clearance here is in the API, with alerts when new ones post.